Dindolyl Methane, or DIM as it’s commonly known as, is a well-known supplement for bodybuilders and others who are interested in increasing the growth of their muscles. Recent research has shown that DIM could pose health hazards. For instance, DIM can cause serious liver damage when consumed in excess. A related risk is kidney damage, which could lead to kidney failure. Many bodybuilders and athletes are concerned about the long-term health risks associated with DIM.
The majority of people take a diindolylmethane supplement to improve the production of testosterone. It is known that testosterone functions as an androgen. This means that it can trigger hormonal changes in tissues. Studies have proven DIM to mimic the effects both of testosterone and other hormones. Certain manufacturers have added diindolylmethane (DIM) to their products to increase their popularity in male circles, as men produce more testosterone than women do. The concept is that men respond to a product which mimics the effects of testosterone naturally produced.
This is why many companies advertise DIM as a cancer suppressor. Diindolylmethane is a fact that it does decrease the growth of tumors in laboratory animals, but these animals were injected with the drug, not administered orally. For humans to achieve the same result diindolylmethane needs to be taken in high doses for a long duration. The animals studied did not show signs of cancer for many years. However, they all developed liver disease after consuming excessive amounts of diindolylmethane. For a thorough look at how DIM functions in the body, you should consult a physician.
According to the US National Institute of Environmental Health Safety and Security, the only way to demonstrate that DIM is effective in treating breast cancer is to conduct an experiment where cells from healthy breast cancer cells are exposed to high doses of diindolylmethane over a prolonged period of time. Like all chemicals, there are both pros and cons to using it. Pros include the ability to mimic hormones. This allows you to create insulin that can stop the growth of cancer cells. The downsides are that diindolylmethane also produces a potentially harmful chemical called DMSO. Read more about best diindolylmethane supplement here.
One of the most popular claims about diindolylmethane’s usage as an treatment for various ailments is that it functions as an anti-cancer, natural, antibacterial, and anti-fungal agent. These claims were rejected by the National Institute of Health after an exhaustive review of supporting evidence. According to the Institute of Chemical Technology, there were no studies conducted to support this assertion. In an in-depth examination of the safety profile of the firestone the Institute of Chemical Safety concluded that the evidence of pharmaceutical companies about the benefits for humans of diindolylmethane were not reliable.
Van der Goes and. al. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, et al. have highlighted the potential dangers of diindolylmethane usage, which include allergic reactions and skin rashes asthma attacks, as well as dizziness, headaches and respiratory issues. They also said that the recommended daily allowance for this chemical is 0.2 milligrams or one tenth of one teaspoon. It is unclear what the concentration will be when this chemical is mixed with other compounds. This substance is not considered safe because it has not been thoroughly examined.
The abstract of the view shows the use of diindolylmethane in cancer treatment is based on the idea that intracellular inhibition of pyruvate metabolism through flavenoids is a possibility to block and prevents accumulation of oxalates and pyruvate metabolites in renal tubule cells. However, the drug metabiplicate toxicology studies didn’t provide convincing evidence that consumption of this chemical results in an overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the company that manufactures firestone Tincture is currently completing two major trials in Europe and the United States.
The abstract of the view also demonstrates that diindolylmethane’s usage in cancer treatment is based on the concept of inhibiting intracellular inhibition by flavenoids of pyruvate metabolism and thus stopping the accumulation of adenine and oxalates within the renal tubule cells. However, the drug metabiplicate toxicology studies did not provide convincing evidence that the consumption of this chemical can cause an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescription drug. According to the FDA the company that makes firestone Tincture is currently conducting two major trials in Europe and the United States. According to the FDA the company that produces firestone tincture is in the process of conducting two major trials in Europe and one in the United States.